Not Signed In -
Meloxicam |
Mobic |
Meloxicam Systematic (IUPAC) name 9-[hydroxy-[(5-methyl-1,3-thiazol-2-yl) amino]methylidene] -8-methyl-7,7-dioxo-7$l^{ 6}- thia-8-azabicyclo[4.4.0]deca-1,3,5-trien-10-one Identifiers CAS number 71125-38-7 ATC code M01AC06 PubChem 5281106 DrugBank APRD00529 Chemical data Formula C14H13N3O4S2 Mol. weight 351.403 g/mol Pharmacokinetic data Bioavailability ? Protein binding 99.4% Metabolism ? Half life 15 hours-20 hours Excretion ? Thera ...
Wikipedia - [full article]
Meloxicam Clinical Trials
- A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis
ClinicalTrials.gov Identifier: NCT00239395 - Completed
Osteoarthritis
- A multi-center trial to compare the efficacy and safety of three doses of Meloxicam and placebo in patients with Rheumatoid Arthritis.
ClinicalTrials.gov Identifier: NCT00042068 - Completed
Rheumatoid Arthritis
- A Study to Compare Meloxicam IM Once Daily vs. Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00239382 - Completed
Arthritis, Rheumatoid
- Mobicox
ClinicalTrials.gov Identifier: NCT00152919 - Recruiting
Prostatic Neoplasms
- Meloxicam suspension in Juvenile Rheumatoid Arthritis (JRA)
ClinicalTrials.gov Identifier: NCT00034853 - Completed
Juvenile Rheumatoid Arthritis
- A One Year Double-Blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in JRA/JIA
ClinicalTrials.gov Identifier: NCT00279747 - Completed
Arthritis, Juvenile Rheumatoid
- A Study of Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
ClinicalTrials.gov Identifier: NCT00274482 - Completed
Arthritis, Juvenile Rheumatoid
email this page
print this page
bookmark this page
feedback on this page
